BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12165863)

  • 1. Frequent mutations of the Trp53, Hras1 and beta-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice.
    Zhuang SM; Wiseman RW; Söderkvist P
    Oncogene; 2002 Aug; 21(36):5643-8. PubMed ID: 12165863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas.
    Choi YW; Heath EI; Heitmiller R; Forastiere AA; Wu TT
    Mod Pathol; 2000 Oct; 13(10):1055-9. PubMed ID: 11048797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability.
    Fukushima H; Yamamoto H; Itoh F; Horiuchi S; Min Y; Iku S; Imai K
    J Exp Clin Cancer Res; 2001 Dec; 20(4):553-9. PubMed ID: 11876551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-phenotype relationships in hepatocellular tumors from mice and man.
    Stahl S; Ittrich C; Marx-Stoelting P; Köhle C; Altug-Teber O; Riess O; Bonin M; Jobst J; Kaiser S; Buchmann A; Schwarz M
    Hepatology; 2005 Aug; 42(2):353-61. PubMed ID: 15965925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
    Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
    Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli.
    Bläker H; Sutter C; Kadmon M; Otto HF; Von Knebel-Doeberitz M; Gebert J; Helmke BM
    Genes Chromosomes Cancer; 2004 Oct; 41(2):93-8. PubMed ID: 15287021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. o-Nitrotoluene-induced large intestinal tumors in B6C3F1 mice model human colon cancer in their molecular pathogenesis.
    Sills RC; Hong HL; Flake G; Moomaw C; Clayton N; Boorman GA; Dunnick J; Devereux TR
    Carcinogenesis; 2004 Apr; 25(4):605-12. PubMed ID: 14688030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities of the APC/beta-catenin pathway in endometrial cancer.
    Moreno-Bueno G; Hardisson D; Sánchez C; Sarrió D; Cassia R; García-Rostán G; Prat J; Guo M; Herman JG; Matías-Guiu X; Esteller M; Palacios J
    Oncogene; 2002 Nov; 21(52):7981-90. PubMed ID: 12439748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.
    Chen YW; Jeng YM; Yeh SH; Chen PJ
    Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APC and p53 mutations in de novo colorectal adenocarcinomas.
    Aoki T; Takeda S; Yanagisawa A; Kato Y; Ajioka Y; Watanabe H; Kudo S; Nakamura Y
    Hum Mutat; 1994; 3(4):342-6. PubMed ID: 8081386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.
    Harada N; Miyoshi H; Murai N; Oshima H; Tamai Y; Oshima M; Taketo MM
    Cancer Res; 2002 Apr; 62(7):1971-7. PubMed ID: 11929813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway.
    Tomita H; Yamada Y; Oyama T; Hata K; Hirose Y; Hara A; Kunisada T; Sugiyama Y; Adachi Y; Linhart H; Mori H
    Cancer Res; 2007 May; 67(9):4079-87. PubMed ID: 17483318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in Apc and p53 synergize to promote mammary neoplasia.
    Méniel V; Hay T; Douglas-Jones A; Sansom OJ; Clarke AR
    Cancer Res; 2005 Jan; 65(2):410-6. PubMed ID: 15695381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling.
    Kielman MF; Rindapää M; Gaspar C; van Poppel N; Breukel C; van Leeuwen S; Taketo MM; Roberts S; Smits R; Fodde R
    Nat Genet; 2002 Dec; 32(4):594-605. PubMed ID: 12426568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations of p53 and ras genes in 1,3-butadiene- and 2',3'-dideoxycytidine-induced lymphomas.
    Zhuang SM; Cochran C; Goodrow T; Wiseman RW; Söderkvist P
    Cancer Res; 1997 Jul; 57(13):2710-4. PubMed ID: 9205081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice.
    Wang Y; Wang Y; Stoner G; You M
    Cancer Res; 1993 Apr; 53(7):1620-4. PubMed ID: 8453632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A beta-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors.
    Loeppen S; Koehle C; Buchmann A; Schwarz M
    Carcinogenesis; 2005 Jan; 26(1):239-48. PubMed ID: 15471898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane.
    Takahashi M; Nakatsugi S; Sugimura T; Wakabayashi K
    Carcinogenesis; 2000 Jun; 21(6):1117-20. PubMed ID: 10836998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.